| dalfampridine / Generic mfg. |
ACTRN12613000439741: A clinical and electrophysiological study of the effects of
4-aminopyridine on upper limb impairment in Multiple Sclerosis
|
|
|
| Not yet recruiting | 4 | 30 | | | Austin Health, National Health and Medical Research Council - funding the study doctor via a postgraduate scholarship. | Multiple Sclerosis | | | | |
ACTRN12613000331730: A placebo-controlled, randomized, double-blind trial of the effects of modified release 4-aminopyridine on upper limb impairment in Multiple Sclerosis |
|
|
| Not yet recruiting | 4 | 60 | | | Austin Health, Biogen Idec, National Health and Medical Research Council (NHMRC) | Multiple Sclerosis | | | | |
2013-001409-10: Fampyra and T cell Immunity in Multiple Sclerosis; a study of the Fampyra induced immunomodulatory T cell responses in MS |
|
|
| Ongoing | 4 | 40 | Europe | Fampyra, Tablet, Fampyra | Odense University Hospital, Odense University Hospital | Multiple Sclerosis, Multiple Sclerosis, Diseases [C] - Nervous System Diseases [C10] | | | | |
2014-003498-41: Effects of dalfampridine on mobility in the context of daily life |
|
|
| Ongoing | 4 | 51 | Europe | Tablet, Fampyra | Medical University of Vienna, Medical University of Vienna, Department of Neurology, Biogen Idec | Motor behaviour and cognition in multiple sclerosis patients, Motor behaviour and cognition in multiple sclerosis patients, Diseases [C] - Nervous System Diseases [C10] | | | | |
2014-004650-34: New strategies for diagnostic, therapeutic and clinical care in neurological diseases Nuove strategie per la diagnosi, la terapia e la gestione medica nelle malattie neurologiche |
|
|
| Ongoing | 4 | 45 | Europe | Tablet, FAMPYRA - 10 MG - COMPRESSA A RILASCIO PROLUNGATO - USO ORALE - FLACONE (HDPE) 56 COMPRESSE (4 FLACONI DA 14) | IRCCS FONDAZIONE ISTITUTO NEUROLOGICO NAZIONALE C. MONDINO, Ministero della Salute | Multiple sclerosis with cerebellar ataxia Sclerosi multipla con atassia cerebellare, Multiple sclerosis Sclerosi multipla, Diseases [C] - Nervous System Diseases [C10] | | | | |
AmpPT, NCT06136728: Dalfampridine Combined With Physical Therapy for Mobility Impairment in Multiple Sclerosis |
|
|
| Not yet recruiting | 4 | 48 | US | Dalfampridine 10 MG [Ampyra], Ampyra, Physical therapy, Dalfampridine plus physical therapy, Combined drug and behavioral | MGH Institute of Health Professions | Multiple Sclerosis | 01/26 | 06/26 | | |
